BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12373287)

  • 1. The role of O-linked protein glycosylation in beta-cell dysfunction.
    Konrad RJ; Kudlow JE
    Int J Mol Med; 2002 Nov; 10(5):535-9. PubMed ID: 12373287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.
    Konrad RJ; Zhang F; Hale JE; Knierman MD; Becker GW; Kudlow JE
    Biochem Biophys Res Commun; 2002 Apr; 293(1):207-12. PubMed ID: 12054585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins.
    Roos MD; Xie W; Su K; Clark JA; Yang X; Chin E; Paterson AJ; Kudlow JE
    Proc Assoc Am Physicians; 1998; 110(5):422-32. PubMed ID: 9756093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells.
    Hanover JA; Lai Z; Lee G; Lubas WA; Sato SM
    Arch Biochem Biophys; 1999 Feb; 362(1):38-45. PubMed ID: 9917327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloxan is an inhibitor of O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.
    Lee TN; Alborn WE; Knierman MD; Konrad RJ
    Biochem Biophys Res Commun; 2006 Dec; 350(4):1038-43. PubMed ID: 17045574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.
    Konrad RJ; Mikolaenko I; Tolar JF; Liu K; Kudlow JE
    Biochem J; 2001 May; 356(Pt 1):31-41. PubMed ID: 11336633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified method of islet isolation preserves the ability of pancreatic islets to increase protein O-glycosylation in response to glucose and streptozotocin.
    Konrad RJ; Liu K; Kudlow JE
    Arch Biochem Biophys; 2000 Sep; 381(1):92-8. PubMed ID: 11019824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity.
    Lee TN; Alborn WE; Knierman MD; Konrad RJ
    Biochem Pharmacol; 2006 Sep; 72(6):710-8. PubMed ID: 16844097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosolic O-GlcNAc accumulation is not involved in beta-cell death in HIT-T15 or Min6.
    Okuyama R; Yachi M
    Biochem Biophys Res Commun; 2001 Sep; 287(2):366-71. PubMed ID: 11554736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxin-10 interacts with O-GlcNAc transferase OGT in pancreatic beta cells.
    Andrali SS; März P; Ozcan S
    Biochem Biophys Res Commun; 2005 Nov; 337(1):149-53. PubMed ID: 16182253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
    Chatham JC; Nöt LG; Fülöp N; Marchase RB
    Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog.
    Toleman C; Paterson AJ; Shin R; Kudlow JE
    Biochem Biophys Res Commun; 2006 Feb; 340(2):526-34. PubMed ID: 16376298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues.
    Yki-Järvinen H; Vogt C; Iozzo P; Pipek R; Daniels MC; Virkamäki A; Mäkimattila S; Mandarino L; DeFronzo RA; McClain D; Gottschalk WK
    Diabetologia; 1997 Jan; 40(1):76-81. PubMed ID: 9028721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [O-GlcNAc glycosylation and regulation of cell signaling].
    Issad T
    Med Sci (Paris); 2010; 26(8-9):753-9. PubMed ID: 20819714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
    Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
    Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets.
    Konrad RJ; Janowski KM; Kudlow JE
    Biochem Biophys Res Commun; 2000 Jan; 267(1):26-32. PubMed ID: 10623569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.